These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 26328024)
1. Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet. Wong GL World J Hepatol; 2015 Aug; 7(18):2133-5. PubMed ID: 26328024 [TBL] [Abstract][Full Text] [Related]
2. Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study. Li GJ; Chen QY; Harrison TJ; Wang XY; Hu LP; Yang QL; Li KW; Fang ZL Cancer Biomark; 2017; 18(3):241-248. PubMed ID: 28085009 [TBL] [Abstract][Full Text] [Related]
3. Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection. Caviglia GP; Abate ML; Petrini E; Gaia S; Rizzetto M; Smedile A Hepatol Res; 2016 Mar; 46(3):E130-5. PubMed ID: 26082262 [TBL] [Abstract][Full Text] [Related]
4. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma. Choi J; Kim GA; Han S; Lee W; Chun S; Lim YS Hepatology; 2019 May; 69(5):1983-1994. PubMed ID: 30153338 [TBL] [Abstract][Full Text] [Related]
6. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels. Hadziyannis E; Sialevris K; Georgiou A; Koskinas J Oncol Rep; 2013 Feb; 29(2):835-9. PubMed ID: 23174906 [TBL] [Abstract][Full Text] [Related]
7. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. Song PP; Xia JF; Inagaki Y; Hasegawa K; Sakamoto Y; Kokudo N; Tang W World J Gastroenterol; 2016 Jan; 22(1):262-74. PubMed ID: 26755875 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Volk ML; Hernandez JC; Su GL; Lok AS; Marrero JA Cancer Biomark; 2007; 3(2):79-87. PubMed ID: 17522429 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology and surveillance of hepatocellular carcinoma. Kim DY; Han KH Liver Cancer; 2012 Jun; 1(1):2-14. PubMed ID: 24159567 [TBL] [Abstract][Full Text] [Related]
10. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. Tong MJ; Blatt LM; Kao VW J Gastroenterol Hepatol; 2001 May; 16(5):553-9. PubMed ID: 11350553 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of α-fetoprotein-L3 and Golgi protein 73 detection in diagnosis of hepatocellular carcinoma. Jia Z; Wang L; Liu C; Yu Z; Chai L; Zhao M Contemp Oncol (Pozn); 2014; 18(3):192-6. PubMed ID: 25520580 [TBL] [Abstract][Full Text] [Related]
12. On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir. Wong GL; Chan HL; Tse YK; Chan HY; Tse CH; Lo AO; Wong VW Hepatology; 2014 Mar; 59(3):986-95. PubMed ID: 24123097 [TBL] [Abstract][Full Text] [Related]
13. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma. Yao M; Zhao J; Lu F Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252 [TBL] [Abstract][Full Text] [Related]
14. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Sterling RK; Jeffers L; Gordon F; Venook AP; Reddy KR; Satomura S; Kanke F; Schwartz ME; Sherman M Clin Gastroenterol Hepatol; 2009 Jan; 7(1):104-13. PubMed ID: 18849011 [TBL] [Abstract][Full Text] [Related]
15. Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma. Sassa T; Kumada T; Nakano S; Uematsu T Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1387-92. PubMed ID: 10654799 [TBL] [Abstract][Full Text] [Related]
16. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients. Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance. Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study. Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780 [TBL] [Abstract][Full Text] [Related]
19. Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma. Zhan Z; Guan Y; Mew K; Zeng W; Peng M; Hu P; Yang Y; Lu Y; Ren H Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G305-G312. PubMed ID: 31736338 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone. Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Yamamoto M; Takasaki K; Nakano M J Gastroenterol Hepatol; 2002 Jul; 17(7):772-8. PubMed ID: 12121507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]